RO76563A2 - Procedeu de stabilizare a unui vaccin antiherpetic - Google Patents
Procedeu de stabilizare a unui vaccin antiherpeticInfo
- Publication number
- RO76563A2 RO76563A2 RO9814179A RO9814179A RO76563A2 RO 76563 A2 RO76563 A2 RO 76563A2 RO 9814179 A RO9814179 A RO 9814179A RO 9814179 A RO9814179 A RO 9814179A RO 76563 A2 RO76563 A2 RO 76563A2
- Authority
- RO
- Romania
- Prior art keywords
- vaccine
- antiherpical
- stabilizing
- procedure
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92706978A | 1978-07-21 | 1978-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
RO76563A2 true RO76563A2 (ro) | 1981-04-30 |
Family
ID=25454121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RO9814179A RO76563A2 (ro) | 1978-07-21 | 1979-07-12 | Procedeu de stabilizare a unui vaccin antiherpetic |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0008255B1 (es) |
JP (1) | JPS5519271A (es) |
AT (1) | ATE3058T1 (es) |
AU (1) | AU532186B2 (es) |
DE (1) | DE2965191D1 (es) |
DK (1) | DK306379A (es) |
ES (1) | ES482549A0 (es) |
HU (1) | HU182530B (es) |
IE (1) | IE48379B1 (es) |
PL (1) | PL217216A1 (es) |
PT (1) | PT69953A (es) |
RO (1) | RO76563A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
FR2804026B1 (fr) | 2000-01-21 | 2004-06-11 | Merial Sas | Vaccination contre l'herpesvirose canine et vaccins |
EP3246400B1 (en) | 2012-01-09 | 2019-10-23 | Sanofi Pasteur Biologics, LLC | Purification of herpes virus |
WO2013177172A2 (en) | 2012-05-21 | 2013-11-28 | Sanofi Pasteur Limited | Herpesvirus compositions and related methods |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3783098A (en) * | 1971-08-10 | 1974-01-01 | Cornell Res Foundation Inc | Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same |
US3981771A (en) * | 1973-07-19 | 1976-09-21 | Martin Sevoian | Marek's disease vaccine |
US3959466A (en) * | 1974-04-15 | 1976-05-25 | The Wistar Institute | Highly attenuated cytomegalovirus vaccine and production thereof |
-
1979
- 1979-07-10 AU AU48820/79A patent/AU532186B2/en not_active Ceased
- 1979-07-12 DE DE7979400495T patent/DE2965191D1/de not_active Expired
- 1979-07-12 AT AT79400495T patent/ATE3058T1/de not_active IP Right Cessation
- 1979-07-12 EP EP19790400495 patent/EP0008255B1/en not_active Expired
- 1979-07-12 RO RO9814179A patent/RO76563A2/ro unknown
- 1979-07-17 ES ES482549A patent/ES482549A0/es active Granted
- 1979-07-19 PL PL21721679A patent/PL217216A1/xx unknown
- 1979-07-20 HU HU79ME2285A patent/HU182530B/hu unknown
- 1979-07-20 PT PT6995379A patent/PT69953A/pt not_active IP Right Cessation
- 1979-07-20 DK DK306379A patent/DK306379A/da not_active Application Discontinuation
- 1979-07-21 JP JP9214579A patent/JPS5519271A/ja active Granted
- 1979-08-08 IE IE1376/79A patent/IE48379B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE3058T1 (de) | 1983-04-15 |
DE2965191D1 (en) | 1983-05-19 |
EP0008255A1 (en) | 1980-02-20 |
EP0008255B1 (en) | 1983-04-13 |
ES8107300A1 (es) | 1980-12-16 |
AU532186B2 (en) | 1983-09-22 |
ES482549A0 (es) | 1980-12-16 |
HU182530B (en) | 1984-01-30 |
JPS5519271A (en) | 1980-02-09 |
DK306379A (da) | 1980-01-22 |
IE48379B1 (en) | 1984-12-26 |
PL217216A1 (es) | 1980-12-15 |
AU4882079A (en) | 1980-01-24 |
JPS6332768B2 (es) | 1988-07-01 |
PT69953A (en) | 1979-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE105334T1 (de) | Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. | |
RO76563A2 (ro) | Procedeu de stabilizare a unui vaccin antiherpetic | |
SE7602871L (sv) | Vaccin for aktiv immunisering | |
DK16087D0 (da) | Mastitis-vaccine | |
DE69333730D1 (de) | Impfstoff, der acemannan als adjuvans enthält | |
ATE86119T1 (de) | Lebendvaccine fuer ansteckungskrankheiten von kueken. | |
DZ1550A1 (fr) | Vaccin depourvu de cellules contre le virus de la maladie marek. | |
ATE109004T1 (de) | Toleranzinduktion gegenüber einem fremdantigen. | |
DE3279264D1 (en) | Method of immunizing pigs against aujeszky's disease | |
DK569985D0 (da) | Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus | |
ATE18007T1 (de) | Hepatitisimpfstoff. | |
DK257887A (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
ATE318300T1 (de) | Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe | |
Felfe et al. | Trends in production of foot-and-mouth disease vaccine. | |
Glaner et al. | 30-Year record of swine fever vaccine production in Insel Riems. | |
Szemeredi et al. | Guinea pig model experiment for testing the efficiency of leptospiral vaccine. | |
GB1065875A (en) | Measles vaccine attenuated through avian choric-allantoic membrane | |
SE8400934D0 (sv) | Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner |